Aperio Group’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$7.15M Buy
47,075
+5,288
+13% +$803K 0.02% 681
2020
Q3
$4.22M Sell
41,787
-3,728
-8% -$377K 0.01% 799
2020
Q2
$5.51M Buy
45,515
+18,938
+71% +$2.29M 0.02% 700
2020
Q1
$2.52M Buy
26,577
+3,414
+15% +$324K 0.01% 925
2019
Q4
$2.04M Buy
23,163
+3,327
+17% +$293K 0.01% 1084
2019
Q3
$1.58M Sell
19,836
-11,689
-37% -$932K 0.01% 1161
2019
Q2
$2.46M Sell
31,525
-56,276
-64% -$4.39M 0.01% 969
2019
Q1
$10.3M Buy
87,801
+8,279
+10% +$972K 0.04% 451
2018
Q4
$8.66M Sell
79,522
-33,633
-30% -$3.66M 0.04% 454
2018
Q3
$14.5M Buy
113,155
+23,489
+26% +$3M 0.06% 337
2018
Q2
$10.1M Buy
89,666
+42,323
+89% +$4.79M 0.05% 433
2018
Q1
$5.32M Sell
47,343
-18,532
-28% -$2.08M 0.03% 626
2017
Q4
$9.75M Buy
65,875
+5,305
+9% +$785K 0.05% 424
2017
Q3
$7.1M Sell
60,570
-2,096
-3% -$246K 0.04% 486
2017
Q2
$8.13M Sell
62,666
-8,136
-11% -$1.06M 0.05% 432
2017
Q1
$9.59M Buy
70,802
+19,603
+38% +$2.65M 0.07% 350
2016
Q4
$7.34M Buy
51,199
+16,888
+49% +$2.42M 0.06% 393
2016
Q3
$4.05M Buy
34,311
+14,102
+70% +$1.66M 0.03% 603
2016
Q2
$2.14M Sell
20,209
-292
-1% -$30.9K 0.02% 779
2016
Q1
$2.29M Buy
20,501
+8,422
+70% +$939K 0.02% 731
2015
Q4
$1.89M Buy
12,079
+3,874
+47% +$607K 0.02% 773
2015
Q3
$1.08M Buy
8,205
+1,308
+19% +$172K 0.01% 944
2015
Q2
$1.2M Buy
6,897
+1,121
+19% +$195K 0.01% 897
2015
Q1
$996K Buy
5,776
+230
+4% +$39.7K 0.01% 942
2014
Q4
$718K Buy
5,546
+209
+4% +$27.1K 0.01% 1043
2014
Q3
$687K Sell
5,337
-107
-2% -$13.8K 0.01% 992
2014
Q2
$482K Buy
5,444
+1,102
+25% +$97.6K 0.01% 1144
2014
Q1
$408K Buy
+4,342
New +$408K 0.01% 1432
2013
Q4
Sell
-3,835
Closed -$302K 1338
2013
Q3
$302K Buy
+3,835
New +$302K 0.01% 1416